Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Titorenko K"'
Autor:
Hijiya N; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY., Maschan A; Dmitrii Rogachev Federal Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Rizzari C; Pediatria, Fondazione IRCSS San Gerardo dei Tintori, Universitá di Milano-Bicocca, Monza, Italy., Shimada H; Department of Pediatrics, Keio University School of Medicine, Shinjuku-ku, Japan., Dufour C; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Giannina Gaslini, Genova, Italy., Goto H; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan., Kang HJ; Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.; Seoul National University Cancer Research Institute, Seoul, South Korea.; Seoul National University Children's Hospital, Seoul, South Korea.; Wide River Institute of Immunology, Hongcheon-gun, South Korea., Guinipero T; Nationwide Children's Hospital, The Ohio State University, Columbus, OH., Karakas Z; Pediatric Hematology/Oncology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey., Bautista F; Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, Hospital Niño Jesús, Madrid, Spain.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Ducassou S; Groupe Hospitalier Pellegrin-Hôpital des Enfants, Bordeaux, France., Yoo KH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands., Millot F; Unité d'Onco-Hématologie Pédiatrique, Centre d'Investigation Clinique (CIC) 1402 INSERM, Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, France., Patterson BC; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA., Samis J; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL., Izquierdo M; Novartis Pharma AG, Basel, Switzerland., Titorenko K; Novartis Pharmaceuticals Corporations, Munich, Germany., Li S; Novartis Pharma AG, Basel, Switzerland., Sosothikul D; Intergrative and Innovative Hematology/Oncology Research Unit, Division of Hematology/Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publikováno v:
Blood advances [Blood Adv] 2023 Dec 12; Vol. 7 (23), pp. 7279-7289.
Publikováno v:
IOP Conference Series: Earth & Environmental Science; 2022, Vol. 1010 Issue 1, p1-8, 8p
Autor:
Titorenko, K V, Zhichkin, K A
Publikováno v:
IOP Conference Series: Earth & Environmental Science; 4/20/2021, Vol. 723, p1-8, 8p
Autor:
Titorenko, K, Zhichkin, K
Publikováno v:
IOP Conference Series: Earth & Environmental Science; 2021, Vol. 677, p1-6, 6p
Autor:
Hijiya N; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY., Maschan A; Dmitrii Rogachev Federal Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Rizzari C; Department of Pediatrics, Pediatric Hematology Oncology Unit, University of Milano Bicocca, Monza Brianza per il Bambino e la sua Mamma (MBBM) Foundation, Azienda Socio Sanitaria Territoriale (ASST), Monza, Italy., Shimada H; Keio University School of Medicine, Shinjuku-ku, Japan., Dufour C; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Giannina Gaslini, Genoa, Italy., Goto H; Kanagawa Children's Medical Center, Yokohama, Japan., Kang HJ; Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.; Wide River Institute of Immunology, Hongcheon-gun, South Korea., Guinipero T; Nationwide Children's Hospital, The Ohio State University, Columbus, OH., Karakas Z; Department of Pediatric Hematology/Oncology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey., Bautista F; Hospital Niño Jesus, Madrid, Spain., Ducassou S; Groupe Hospitalier Pellegrin-Hôpital des Enfants, Bordeaux, France., Yoo KH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Zwaan CM; Department of Pediatric Oncology/Hematology, Erasmus Medical Center (MC)-Sophia Children's Hospital, Rotterdam, The Netherlands.; Innovative Therapies for Children with Cancer (ITCC) Consortium, The Netherlands., Millot F; Unité d'Onco-Hématologie Pédiatrique, Centre d'Investigation Clinique (CIC) 1402 INSERM, Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, France., Patterson B; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA., Samis J; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL., Aimone P; Novartis Pharma AG, Basel, Switzerland., Allepuz A; Novartis Pharma AG, Basel, Switzerland., Titorenko K; Novartis Pharmaceuticals Corporation, Moscow, Russian Federation; and., Sosothikul D; Clinical Research for Holistic Management in Pediatric Hematology and Oncology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publikováno v:
Blood advances [Blood Adv] 2021 Jul 27; Vol. 5 (14), pp. 2925-2934.
Autor:
Kantarjian HM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. hkantarjian@mdanderson.org., Hughes TP; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.; University of Adelaide, Adelaide, SA, Australia., Larson RA; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Kim DW; Seoul St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, South Korea., Issaragrisil S; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., le Coutre P; Charité - Universitätsmedizin Berlin, Berlin, Germany., Etienne G; Hematology Department, Institut Bergonié, Bordeaux, France., Boquimpani C; Hemorio, Institute of Hematology, Rio de Janeiro, Brazil.; Oncoclínica Rio de Janeiro, Rio de Janeiro, Brazil., Pasquini R; Universidade Federal do Paraná, Hospital de Clinicas, Curitiba, Paraná, Brazil., Clark RE; Royal Liverpool University Hospital, Liverpool, United Kingdom., Dubruille V; Clinical Hematology, Nantes University Hospital, Nantes, France., Flinn IW; Sarah Cannon Research Institute, Nashville, TN, USA., Kyrcz-Krzemien S; Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland., Medras E; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland., Zanichelli M; Instituto de Tratamento do Câncer Infantil, Instituto da Criança, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil., Bendit I; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil., Cacciatore S; Novartis Pharma AG, Basel, Switzerland., Titorenko K; Novartis Pharmaceuticals Corporation, Moscow, Russian Federation., Aimone P; Novartis Pharma AG, Basel, Switzerland., Saglio G; Division of Internal Medicine and Hematology, University of Turin, Turin, Italy., Hochhaus A; Universitätsklinikum Jena, Jena, Germany.
Publikováno v:
Leukemia [Leukemia] 2021 Jul; Vol. 35 (7), pp. 2142-2143.
Autor:
Radich JP; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Hochhaus A; Abteilung Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Germany., Masszi T; Semmelweis University, Budapest, Hungary., Hellmann A; Medical University of Gdańsk, Gdańsk, Poland., Stentoft J; Aarhus University Hospital, Aarhus, Denmark., Casares MTG; Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain., García-Gutiérrez JV; Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain., Conneally E; St James's Hospital, Dublin, Ireland., le Coutre PD; Charité-Universitätsmedizin Berlin, Berlin, Germany., Gattermann N; Universitätsklinikum Düsseldorf, Düsseldorf, Germany., Martino B; Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy., Saussele S; III. Med. Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany., Giles FJ; Developmental Therapeutics Consortium, Chicago, IL, USA., Ross DM; Division of Haematology, SA Pathology, Royal Adelaide Hospital, Adelaide, Australia., Aimone P; Novartis Pharma AG, Basel, Switzerland., Li S; Novartis Pharma AG, Basel, Switzerland., Titorenko K; Novartis Pharmaceuticals Corporation, Moscow, Russian Federation., Saglio G; University of Turin, Orbassano, Italy. giuseppe.saglio@unito.it.
Publikováno v:
Leukemia [Leukemia] 2021 May; Vol. 35 (5), pp. 1344-1355. Date of Electronic Publication: 2021 Mar 11.
Autor:
Kantarjian HM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. hkantarjian@mdanderson.org., Hughes TP; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.; University of Adelaide, Adelaide, SA, Australia., Larson RA; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Kim DW; Seoul St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, South Korea., Issaragrisil S; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., le Coutre P; Charité - Universitätsmedizin Berlin, Berlin, Germany., Etienne G; Hematology Department, Institut Bergonié, Bordeaux, France., Boquimpani C; Hemorio, Institute of Hematology, Rio de Janeiro, Brazil.; Oncoclínica Rio de Janeiro, Rio de Janeiro, Brazil., Pasquini R; Universidade Federal do Paraná, Hospital de Clinicas, Curitiba, Paraná, Brazil., Clark RE; Royal Liverpool University Hospital, Liverpool, United Kingdom., Dubruille V; Clinical Hematology, Nantes University Hospital, Nantes, France., Flinn IW; Sarah Cannon Research Institute, Nashville, TN, USA., Kyrcz-Krzemien S; Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland., Medras E; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland., Zanichelli M; Instituto de Tratamento do Câncer Infantil, Instituto da Criança, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil., Bendit I; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil., Cacciatore S; Novartis Pharma AG, Basel, Switzerland., Titorenko K; Novartis Pharmaceuticals Corporation, Moscow, Russian Federation., Aimone P; Novartis Pharma AG, Basel, Switzerland., Saglio G; Division of Internal Medicine and Hematology, University of Turin, Turin, Italy., Hochhaus A; Universitätsklinikum Jena, Jena, Germany.
Publikováno v:
Leukemia [Leukemia] 2021 Feb; Vol. 35 (2), pp. 440-453. Date of Electronic Publication: 2021 Jan 07.
Autor:
Rozental A; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel.; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Senior Adult Oncology Program, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Halperin E; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel.; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Leibovitch C; Internal Medicine B, Ashdod Hospital, Samson Assuta, Ashdod, Israel., Barzili M; Hematology and Hemato-Oncology Division, Tel Aviv Medical Center, Tel Aviv, Israel., Michowitz MK; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Shamir Medical Center, Department of Hematology, Zerifin, Israel., Duek A; Hematology Department, Assuta Medical Center, Ashdod, Israel., Rozovski U; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel.; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Extermann M; Senior Adult Oncology Program, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Raanani P; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel.; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Shacham-Abulafia A; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel. shacham.adi@gmail.com.; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. shacham.adi@gmail.com.
Publikováno v:
Annals of hematology [Ann Hematol] 2024 Sep; Vol. 103 (9), pp. 3585-3594. Date of Electronic Publication: 2024 Jun 11.
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.